Authors


Heather Haro

Latest:

The Good, The Bad, and the Missed Opportunity of Mark Cuban Cost Plus Drug Company

The billionaire’s first venture into pharmacy launched earlier this year.


Jay Ackerman

Latest:

Why Artificial Intelligence is Critical to the Success of Value-Based Care

Employing AI-driven technology ensures accurate and timely compliance with industry regulations, mitigates audits and fines, and helps forecast accurate reimbursements.


Connor Iapoce

Latest:

Examining Barriers to Care in Diabetic Retinopathy Screening

Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.


Kristi Rosa

Latest:

Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer Gets Full FDA Approval

Mirvetuximab soravtansine-gynx (Elahere) was first granted FDA accelerated approval in November 2022.


Charles Lee, MD

Latest:

Why Patient Education Is More Important Than Ever

How pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies


Erin Smith

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Celeste Krewson

Latest:

Fish, Omega-3 Fatty Acid Intake Below Recommended Levels Among Pregnant Women

N-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.


Robert Busch, MD

Latest:

Bempedoic Acid for Hypercholesterolemia

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.


AJ Rivosecchi, PharmD

Latest:

Hospital Pharmacies and Budget Management: How Technology Can Help

The hospital pharmacy must play its part by leveraging technology to control the costs of doing business and supporting the enterprise in addition to focusing on patient care.


Jonathan Ogurchak, PharmD, CSP

Latest:

New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.


Steven M. Selbst, MD

Latest:

Preventing Severe Respiratory Infections in Children

A refresher on best interventions for common respiratory disorders in children.


Denise Myshko

Latest:

Ozempic, Other GLP-1 Therapies Caused Major Increase in Medicare Spending

After semaglutide and tirzepatide were approved, and ozempic use continues to rise, Medicare spending is also increasing because of a high demand for GLP-1 therapies.


Allison Inserro

Latest:

COVID-19 National Emergencies to End in May

The public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.



Antonella Santuccione Chadha, MD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Don Creighton

Latest:

Inflation Reduction Act and Its Impact on Pharmaceutical Pricing and Investment Decisions

The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.


Jon Matthew Farber, MD

Latest:

How Vitamin D Can Help Migraines In Young Patients

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.


Fazila Rajab, BDS

Latest:

Holistic Treatment Techniques for Managing Atopic Dermatitis

Patients are finding relief in alternative therapies for this chronic skin disease.


Meg Marzella

Latest:

Racial, Ethnic Inequities Persist in Diabetes Care

Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors


Hayley Virgil

Latest:

Bosutinib Approved by FDA for Pediatric Chronic Myelogenous Leukemia

Positive findings from the phase 1/2 BCHILD study supported the approval decision.


Noah Stansfield

Latest:

FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer Concern

As per US law Section 505(o)(4), the manufacturers are required to make the requested changes, respond with a modified version of the requested changes for review, or respond with a rebuttal within 30 days of the FDA's ask.


Kyle Munz

Latest:

COVID-19 Vaccination Rates Significantly Lower in Patients With Sickle Cell Disease

Patients with SCD are more vulnerable to hospitalization due, in part, to SCD’s impact on the spleen, which filters infections in the blood and is a crucial organ for the immune system.


Clarice Holmes, RN

Latest:

Advanced Health Care Technology Solutions Can Help Both Providers and Payers

Integrating evidence-based treatment protocols through a streamlined approach enables the delivery of higher quality, comprehensive care.


Kelley Detweiler

Latest:

Veterinary Prescriptions Made Easy

How can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?


Christina Davis

Latest:

How to Balance Your Time in the Pharmacy

A shift in mindset and priorities can help you improve staff performance, acquire new patients, and leverage technology for more efficient operations.


Skylar Jeremias

Latest:

IQVIA Predicts Biosimilar, Generic Competition Will Cost Originators $192 Billion by 2028

According to the most recent Global Use of Medicine report issued by the IQVIA Institute for Human Data Science, losses for originator products are projected to rise by over $80 billion over the next 5 years due to market introductions of new biosimilar and generic drugs.


Nirali S. Khusal, PharmD

Latest:

Opicapone Can Help Treat Patients Experiencing “Off” Episodes With Parkinson Disease

Levodopa/carbidopa is currently the gold standard for controlling motor symptoms associated with Parkinson disease.


Carrie Nagorka

Latest:

Cancer Risk Associated With UV Nail Dryers

The safety of gel manicures is under renewed scrutiny after a new study suggested they can cause DNA damage


Ashley E. Kivlichan

Latest:

College Students and Misuse of Substances

The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.


Marian Freedman

Latest:

How Vitamin D Can Help Migraines In Young Patients

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.

© 2024 MJH Life Sciences

All rights reserved.